Figure 1From: MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasiroxChanges of global haert T2* (up) and MRI LIC values (bottom) in TD TI patients treated with different iron chelators in monotherapyBack to article page